1. Severe COVID-19 in HIV/Leishmania infantum coinfected patient: a successfully managed case report.
- Author
-
Farias PCS, Bezerra GSN, Neves PAF, Cabral LP, Júnior WLB, Guedes DL, Xavier AT, Medeiros ZM, Lorena VMB, Araújo PSR, de Queiroz Balbino V, and de Lima Neto RG
- Subjects
- Humans, Female, Middle Aged, Leishmaniasis, Visceral drug therapy, Leishmaniasis, Visceral complications, Leishmaniasis, Visceral diagnosis, Brazil, COVID-19 complications, Coinfection virology, Coinfection parasitology, HIV Infections complications, Leishmania infantum isolation & purification, SARS-CoV-2
- Abstract
Background: Coronavirus disease 2019 originated in China and swiftly spread worldwide, posing a significant threat to public health. Caused by SARS-CoV-2, it manifests as a flu-like illness that can escalate to Acute Respiratory Distress Syndrome, potentially resulting in fatalities. In countries where HIV/Leishmania infantum is endemic, the occurrence of concurrent SARS-CoV-2/HIV/Leishmania infantum infections is a reality, prompting inquiries into appropriate clinical management., Case Presentation: We present the case of a 48-year-old woman who was hospitalized for 36 days across three different hospitals in the state of Pernambuco, Brazil. She was diagnosed with SARS-CoV-2/HIV/L. infantum coinfection. The patient exhibited severe COVID-19 symptoms, including fever, productive cough, and dyspnea. Throughout her hospitalization, she experienced oxygen saturation levels of ≤ 93%, along with fluctuations in blood pressure, respiratory rate, and heart rate. Her blood tests revealed lymphopenia, leukopenia, and neutropenia, while laboratory results indicated abnormal levels of d-dimer, AST, ALT, lactate dehydrogenase, ferritin, and C-reactive protein. A computed tomography scan revealed 75% involvement of the lung parenchyma with patchy ground-glass opacities., Conclusion: Against all odds, the patient was discharged. The leukopenia associated with HIV/L. infantum may have played a decisive role. Further studies are necessary to better understand diagnostic strategies and clinical management measures for HIV/L. infantum coinfected patients who are susceptible to SARS-CoV-2 infection., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF